Associations between arterial stiffness and platelet activation in normotensive overweight and obese young adults

References

• Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 2009;102:248–57
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Nomura S, Miyake T, et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996;88:3456–64
   PubMed Web of Science ®Google Scholar
• Hamilton PK, Lockhart CJ, Quinn CE, McVeigh GE. Arterial stiffness: clinical relevance, measurement and treatment. Clin Sci (Lond) 2007;113:157–70
   PubMed Web of Science ®Google Scholar
• Yamasaki F, Furuno T, Sato K, et al. Association between arterial stiffness and platelet activation. J Hum Hypertens 2005;19:527–33
   PubMed Web of Science ®Google Scholar
• Dotsenko O, Chaturvedi N, Thom SA, et al. Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men. J Thromb Haemost 2007;5:2036–42
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318–27
   PubMed Web of Science ®Google Scholar
• Wang RT, Li Y, Zhu XY, Zhang YN. Increased mean platelet volume is associated with arterial stiffness. Platelets 2011;22:447--51
   PubMed Web of Science ®Google Scholar
• Wildman RP, Mackey RH, Bostom A, et al. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 2003;42:468–73
   PubMed Web of Science ®Google Scholar
• Dellas C, Schafer K, Rohm I, et al. Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity. Thromb Haemost 2008;100:1123–9
   PubMed Web of Science ®Google Scholar
• Davi G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002;288:2008–14
   PubMed Web of Science ®Google Scholar
• Desideri G, Ferri C. Effects of obesity and weight loss on soluble CD40L levels. JAMA 2003;289:1781–2
   PubMed Web of Science ®Google Scholar
• De Pergola G, Pannacciulli N, Coviello M, et al. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis 2008;18:227–32
   PubMed Web of Science ®Google Scholar
• Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005;59:981–2
   PubMed Web of Science ®Google Scholar
• Santilli F, Vazzana N, Liani R, et al. Platelet activation in obesity and metabolic syndrome. Obes Rev 2012;13:27–42
   PubMed Web of Science ®Google Scholar
• Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981;57:199–202
   PubMed Web of Science ®Google Scholar
• Matzdorff AC, Kemkes-Matthes B, Voss R, Pralle H. Comparison of beta-thromboglobulin, flow cytometry, and platelet aggregometry to study platelet activation. Haemostasis 1996;26:98–106
   PubMedGoogle Scholar
• Bernstein AM, Willett WC. Trends in 24-h urinary sodium excretion in the United States, 1957–2003: a systematic review. Am J Clin Nutr 2010;92:1172–80
   PubMed Web of Science ®Google Scholar
• Cooper JN, Tepper P, Barinas-Mitchell E, et al. Serum aldosterone is associated with inflammation and aortic stiffness in normotensive overweight and obese young adults. Clin Exp Hypertens 2012;34:63–70
   PubMed Web of Science ®Google Scholar
• Njoroge JN, El Khoudary SR, Fried LF, et al. High urinary sodium is associated with increased carotid intima-media thickness in normotensive overweight and obese adults. Am J Hypertens 2011;24:70–6
   PubMed Web of Science ®Google Scholar
• Ellis D, Lloyd C, Becker DJ, et al. The changing course of diabetic nephropathy: Low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. Am J Kidney Dis 1996;27:809–18
   PubMed Web of Science ®Google Scholar
• Kimoto E, Shoji T, Shinohara K, et al. Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease. J Am Soc Nephrol 2006;17:2245–52
   PubMed Web of Science ®Google Scholar
• Shetty V, Morrell CH, Najjar SS. Modeling a cross-sectional response variable with longitudinal predictors: an example of pulse pressure and pulse wave velocity. J Appl Stat 2009;36:611–19
   PubMed Web of Science ®Google Scholar
• Malik AR, Kondragunta V, Kullo IJ. Forearm vascular reactivity and arterial stiffness in asymptomatic adults from the community. Hypertension 2008;51:1512–18
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Akishita M, Yu W, et al. Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis 2004;173:13–18
   PubMed Web of Science ®Google Scholar
• Feng D, Lindpaintner K, Larson MG, et al. Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study. Circulation 2001;104:140–4
   PubMed Web of Science ®Google Scholar
• Vita JA, Mitchell GF. Effects of shear stress and flow pulsatility on endothelial function: insights gleaned from external counterpulsation therapy. J Am Coll Cardiol 2003;42:2096–8
   PubMed Web of Science ®Google Scholar
• Safar ME, Blacher J, Jankowski P. Arterial stiffness, pulse pressure, and cardiovascular disease-is it possible to break the vicious circle? Atherosclerosis 2011;218:263–71
   PubMed Web of Science ®Google Scholar
• Jakubowski JA, Adler B, Thompson CB, et al. Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med 1985;105:271–6
   PubMed Web of Science ®Google Scholar
• Csongradi E, Nagy B Jr, Fulop T, et al. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients. Thromb Haemost 2011;106:683–92
   PubMed Web of Science ®Google Scholar
• Ordu S, Ozhan H, Caglar O, et al. Mean platelet volume in patients with dipper and non-dipper hypertension. Blood Press 2010;19:26–30
   PubMed Web of Science ®Google Scholar
• Blann AD, Lip GY, Islim IF, Beevers DG. Evidence of platelet activation in hypertension. J Hum Hypertens 1997;11:607–9
   PubMed Web of Science ®Google Scholar
• Protogerou AD, Papaioannou TG, Blacher J, et al. Central blood pressures: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target? J Hypertens 2007;25:265–72
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, O'Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010;31:1865–71
   PubMed Web of Science ®Google Scholar
• Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res 2005;96:612–16
   PubMed Web of Science ®Google Scholar